Edition:
United Kingdom

Aerpio Pharmaceuticals Inc (ARPO.OQ)

ARPO.OQ on NASDAQ Stock Exchange Capital Market

2.85USD
22 Feb 2019
Change (% chg)

$-0.14 (-4.68%)
Prev Close
$2.99
Open
$2.97
Day's High
$3.24
Day's Low
$2.83
Volume
37,026
Avg. Vol
27,051
52-wk High
$4.35
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 18.82 0.282
Jun '18 1.33 -0.219
Mar '18 0.00 -0.275
FY 2017 Dec '17 0.00 -0.230
Sep '17 0.00 -0.172
Jun '17 0.00 -0.204
Mar '17 0.00 -0.219
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Quarter Ending Jun-19 2 0.00 0.00 0.00 --
Year Ending Dec-19 4 1.25 5.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 4 -0.22 -0.18 -0.28 --
Quarter Ending Jun-19 4 -0.22 -0.18 -0.32 --
Year Ending Dec-19 3 -0.74 -0.64 -0.84 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta -- 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) -- 10.14 5.26
Price to Tangible Book (MRQ) -- 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions -- 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.16 12.76
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) -- 3.50 3.08
LT Debt to Equity (MRQ) -- 18.65 11.38
Total Debt to Equity (MRQ) -- 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.41 12.87
Operating Margin (TTM) -- -184.63 6.19
Operating Margin - 5 Yr. Avg. -- -126.90 8.31
Pre-Tax Margin (TTM) -- -175.33 7.15
Pre-Tax Margin - 5 Yr. Avg. -- -132.69 8.61
Net Profit Margin (TTM) -- -182.03 3.29
Net Profit Margin - 5 Yr. Avg. -- -137.08 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,654,540 842,390,177
Net Income/Employee (TTM) -- 562,104 99,841,827
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) -- 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.39 11.06
Return on Assets - 5 Yr. Avg. -- 5.47 12.20
Return on Investment (TTM) -- 8.92 14.45
Return on Investment - 5 Yr. Avg. -- 6.78 15.87
Return on Equity (TTM) -- 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00

Performance for Aerpio Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.58%
# of Holders: 25
Total Shares Held: 10,789,638
3 Mo. Net Change: -592,797
# New Positions: 9
# Closed Positions: 4
# Increased Positions: 12
# Reduced Positions: 7
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.